FIELD: medicine; pharmaceuticals; food industry.
SUBSTANCE: invention refers to pharmaceutical and food industry, namely to application of Cistanche tubulosa extract for production of product for prevention, retardation or treatment of eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Use of the extract of Cistanche tubulosa for preparing a drug for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein the extract of Cistanche tubulosa contains a component selected from a group consisting of echinacid, actezide, isoachtoiside, tubulozide A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a medicinal agent for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Application of Cistanche tubulosa extract for food product preparation for protection of eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein Cistanche tubulosa extract contains a component selected from the group consisting of echinacoside, actezide, isoachtoiside, tubuloside A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a food product for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Use of the extract of Cistanche tubulosa for preparing a medicinal agent for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein the extract of Cistanche tubulosa contains a component selected from a group consisting of echinacoside, actoteside, isoachtoiside, tubuloside A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a medicinal agent for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light.
EFFECT: agents described above are effective for protecting eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, or for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light.
19 cl, 25 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG FOR GLUCOSE LEVEL REGULATION IN BLOOD | 2014 |
|
RU2637635C2 |
THERAPEUTIC AND NEUROPROTECTIVE PEPTIDES | 2018 |
|
RU2788097C2 |
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
PROPHYLACTIC AND THERAPEUTIC DRUG FOR AGE-RELATED MACULAR DEGENERATION | 2008 |
|
RU2460526C2 |
INHIBITORS OF HYSTONE DEACETYLASE FOR TREATMENT OF DEGENERATIVE EYE DISEASES | 2003 |
|
RU2324483C2 |
COMPOSITION FOR PREVENTING OR TREATING EYE DISEASES, CONTAINING S-ALLYL-L-CYSTEIN AS ACTIVE INGREDIENT, AND PHARMACEUTICAL PREPARATION CONTAINING IT | 2013 |
|
RU2605618C2 |
LOCAL EYE PEPTIDE COMPOSITION | 2010 |
|
RU2561585C2 |
PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES | 2008 |
|
RU2470635C2 |
NANOSTRUCTURED COMPOSITIONS FOR DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING EYE DISEASES | 2015 |
|
RU2726193C2 |
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
Authors
Dates
2019-05-23—Published
2015-07-03—Filed